Presentations

08:00

ANXA1 and FPR signaling promotes immune tolerance by suppressing neutrophil extracellular traps after pediatric liver transplantation

Shuangqing Han (CN)

Bio Abstract

08:10

Regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in adult live donor liver transplantation

Angus Thomson (US)

Bio Abstract

08:20

🎗Liver-resident natural killer cells promote immune tolerance after liver transplantation via the PDL1/PD1 axis: Toward engineered cell therapy

Haitao Huang (CN)

Bio Abstract

08:30

Tumor burden rather than incidence of acute rejection indicates 1-year OFS and RFS

Jiwei Qin (CN)

Bio Abstract

08:37

Pretransplant natural killer cell activity predicts hpatocellular carcinoma recurrence and survival after living donor liver transplantation

Ho Joong Choi (KR)

Bio Abstract

08:44

🎗Integrative Transcriptomics and Machine Learning Identify Inflammatory and Profibrotic signalling as a Central Driver of Immune-Mediated Fibrosis in Chronic Liver Allograft Rejection.

Marco Santillán Pazmiño (AR)

Bio Abstract

08:51

Impact of the high baseline anti-A/B antibody titer on the clinical outcomes in ABO-incompatible living donor liver transplantation

Jai Young Cho (KR)

Bio Abstract

08:56

Iguratimod attenuates chronic allograft fibrosis by inhibiting macrophage–myofibroblast transformation via NCOA4-dependent ferritinophagy

Hongdi Cao (CN)

Bio Abstract